Commercial
Patients to Benefit From EU Agency Releasing Drug Secrets
The European Medicines Agency (EMA) puts patient safety and commercial interests first by giving independent researchers access to clinical trial data.
More Clinical Articles
Commercial
Mobile Health Could Spell the End of the Distinction Between Clinical Trials and ‘Real World Evidence’
With 25% of clinical trial procedures recently being branded 'pointless', could mobile health and real-world evidence signal the turning point in successful product trials?
Commercial
Real World Data and Demonstrating Drug Value
The adoption of real world data in clinical practice to supplement or largely replace clinical trials will remove the challenges of demonstrating the value of medicines to patients, payers and healthcare providers.
Commercial
mHealth, Clinical Trial Recruitment and the Path to True Love
Sometimes life is baffling. All the ingredients for a great love-match are there: compatibility, opportunity, support from those around you...but something’s missing. So it seems for mHealth and clinical trials.
Commercial
Ask the Right Questions: Pfizer’s ‘Failed’ Online Clinical Trial Can Teach Us More Than We Think
Caroline Criado-Perez on why learning recent failings in online clinical trials could hold the keys to successful future attempts.
Commercial
Clinical Trials: How Much Benefit Do Computer Models Add?
Following last week's announcement that new computer models have successfully predicted negative side effects in hundreds of current drugs, Rochelle Sampy asks whether computer modelling is any substitute for traditional patient trials...
Commercial
Patients want direct, guaranteed access to clinical trials
Simon Davies, CEO of Teenage Cancer Trust talks about automatic patient enrollment into clinical trials.
Commercial
Understanding pharma’s drug development costs
Angelo DePalma explores what it costs to bring a new drug to market—and why it matters
Commercial
From ePRO to iPRO: The effect of iPads on adherence and clinical trials
Mary Wieder of Arithmos explores the benefits of using mobile technology for patient-recorded outcomes and clinical trials
Commercial
Pharma forecasting: The use adaptive designs in clinical research
How adaptive design can reduce development times for drug and provide earlier long-term safety data